Boston Scientific BSX Net debt / EBITDA

Net debt / EBITDA at other companies

AbbottABT

2.5×+1.9×

TFX

TeleflexTFX

8.5×+4.3×

Johnson & JohnsonJNJ

0.8×-0.3×

StrykerSYK

1.9×-1.3×

HaemoneticsHAE

2.4×-0.7×

CONMEDCNMD

6.1×+2.3×

FAQ

What is Boston Scientific's net debt / EBITDA?

Boston Scientific (BSX) reported net debt / EBITDA of -0.1× in Q4 2025.

How has Boston Scientific's net debt / EBITDA changed year-over-year?

Boston Scientific's net debt / EBITDA decreased by 102.2% year-over-year, from 2.8× to -0.1×.

What is the long-term trend for Boston Scientific's net debt / EBITDA?

Over 4 years (2021 to 2025), Boston Scientific's net debt / EBITDA has grown at a -64.9% compound annual growth rate (CAGR), from 4× to -0.1×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.